Last updated: March 3, 2026
What is NDC 60687-0479?
NDC 60687-0479 is a proprietary drug product, classified under a specific Therapeutic Class. It is primarily used for [indication], and its formulation is [formulation] with [dosage strength]. The product was approved by the FDA on [approval date].
Market Overview
Market Size and Growth
The global market for [therapeutic class] is projected to reach $X billion by 2025, growing at a CAGR of X% from 2023 to 2025. The growth drivers include increased prevalence of [indication], approval of new indications, and expanded access in emerging markets.
In the US, the treatment of [indication] affects an estimated X million adults annually. The market is segmented into branded and generic segments, with branded therapies accounting for approximately X% of sales in 2022, valued at $X billion.
Competitive Landscape
Major competitors include [drug A], [drug B], and [drug C], with market shares of X%, Y%, and Z%, respectively. The entry of biosimilars and generics influences pricing pressures and market share dynamics.
Regulatory Environment
Regulatory approval pathways for this class have evolved, with FDA approval for [specific indications or formulations] granted on [date]. Key policies impacting pricing include the Medicaid Drug Rebate Program and the Inflation Reduction Act, influencing net pricing and reimbursement strategies.
Price Trends and Projections
Current Pricing
The average wholesale price (AWP) for NDC 60687-0479 is approximately $X per unit. The manufacturer's suggested retail price (MSRP) is $Y, with discounts typically ranging from X–Y%.
Historical Price Changes
Since its market entry in [year], the price has experienced an average annual increase of X%. Price fluctuations correlate with regulatory changes, generic entry, and market demand shifts.
Future Price Projections
Analysts project that the price for NDC 60687-0479 will increase at an annual rate of X% through 2025, reaching approximately $Z per unit. Factors include:
-
Upcoming patent exclusivity extensions until [year].
-
Expected reductions in competition due to delayed biosimilar approvals.
-
Inflation adjustments and supply chain considerations.
Impact of Market Dynamics
The anticipated biosimilar entry in [year] could reduce prices by X%, depending on market acceptance. Additionally, expected policy changes may modify reimbursement and pricing structures.
Revenue and Market Share Forecasts
Approximate revenue for NDC 60687-0479 in 2023 is projected at $X million, with a market share of Y% in its therapeutic class. By 2025, revenue could reach $Z million, assuming stable pricing and market penetration.
Risks and Opportunities
-
Patent litigation or patent cliffs could lead to generic or biosimilar entry, reducing prices.
-
Expanded indications and combination therapies may increase market size and demand.
-
Pricing reforms and payer negotiations could influence achievable prices.
Key Takeaways
-
The drug’s current price is approximately $X per unit, with a projected increase at X% annually until 2025.
-
Market size is projected to grow to $Z billion globally by 2025, driven by rising disease prevalence and expanded indications.
-
Competition from biosimilars and generics is expected to put downward pressure on prices, especially after patent expiry or biosimilar approvals.
-
Regulatory and policy shifts are primary factors influencing pricing strategies and market share.
-
Revenue forecasts depend on market penetration, pricing stability, and competition.
FAQs
What factors influence the price of NDC 60687-0479?
The price is affected by patent protections, competition from biosimilars or generics, regulatory approvals, and reimbursement policies.
How does biosimilar entry impact the market?
Biosimilar entry typically reduces prices by 15–30%, depending on market acceptance and regulatory factors.
Is the drug expected to maintain market exclusivity until 2030?
Patent and exclusivity periods vary; current projections suggest exclusivity until [year], after which generic or biosimilar competition emerges.
What is the key risk to future pricing?
Patent expiration, regulatory changes, and market entry of lower-cost alternatives are primary risks lowering prices.
How might policy reforms alter the market landscape?
Reforms targeting drug pricing, such as price negotiations and inflation caps, could pressure existing prices downward.
References
[1] U.S. Food and Drug Administration. (2023). Drug Approval Reports. https://www.fda.gov/drugs/drug-approvals-and-databases
[2] IQVIA. (2023). The U.S. Prescription Drug Market. https://www.iqvia.com
[3] Centers for Medicare & Medicaid Services. (2023). Drug Rebate and Pricing Policies. https://www.cms.gov
